Monthly Archives - July 2021

Myomo Receives Accreditation from HQAA

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Healthcare Quality Association on Accreditation (HQAA) has certified Myomo meets the accreditation requirements under the Social Security Act and federal regulations. Read more >>

For More Inclusivity In Wine, Our Language Needs to Change

…As the wine world evolves to reach new generations and a wider range of people, so does the language used to describe it. Many have begun to break away from shared verbiage.

“I grew up in Chicago, where there is no ‘forest floor,’” says Alicia Towns Franken, vice president of Archer Roose and head of mentorship at Wine Unify. “If we want more people to drink wine, we have to include them in the words we use to discuss wine.” […]

First Light Diagnostics Receives FDA Clearance for its Rapid Clostridiodes difficile Test on the MultiPath® Analyzer

First Light Diagnostics is developing and commercializing breakthrough automated diagnostic products for rapidly detecting infections and determining optimal treatment. The company announced today that the US Food and Drug Administration (FDA) has cleared its SensiTox™ C. difficile Toxin Test along with its proprietary MultiPath Analyzer to be marketed in the US. Read more >>

Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Akston Shelf-Stable COVID-19 Vaccine at Global Scale

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, today announced a commercial agreement with Seppic S.A., a supplier of specialty healthcare ingredients, for the supply of adjuvant for use in Akston’s COVID-19 Fc fusion protein vaccine candidate, AKS-452. Read more >>